SARS-CoV-2 (COVID-19) Envelope Peptide | 9169P

SARS-CoV-2 (COVID-19) Envelope Peptide | 9169P | Gentaur UK, US & Europe Distribution

Short Description: SARS-CoV-2 (COVID-19) Envelope Peptide

Species: SARS-CoV-2

Location: 14 amino acids near the carboxyl terminus of SARS-CoV-2 (COVID-19) Envelope protein.

Tested Application: Bl

Application: SARS-CoV-2 (COVID-19) Envelope Peptide is used for blocking the activity of the SARS-CoV-2 (COVID-19) Envelope Antibody.

Physical State: Liquid

Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

Concentration: 200 ug/mL

Storage: Store SARS-CoV-2 (COVID-19) Envelope Peptide at -20˚C, stable for one year.

NCBI Official Symbol: E

Alternate Names: SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Envelope protein, E protein

NCBI Gene ID: 43740570

User Note: N/A

NCBI Official Name: Envelope Protein

Background: Gorbalenya. bioRxiv: 2020.

Disclaimer: This product is for research use only.